Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.

Quinlan SC, Pfeiffer RM, Morton LM, Engels EA.

Am J Hematol. 2011 Feb;86(2):206-9. doi: 10.1002/ajh.21911.

2.

Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.

San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P; ESCMID Study Group of Infection in Compromised Hosts.

Clin Microbiol Infect. 2014 Sep;20 Suppl 7:109-18. doi: 10.1111/1469-0691.12534. Review.

3.

Identifying the patient at risk for post-transplant lymphoproliferative disorder.

Cockfield SM.

Transpl Infect Dis. 2001 Jun;3(2):70-8. Review.

PMID:
11395972
4.

Incidence and consequences of post-transplantation lymphoproliferative disorders.

Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B.

J Nephrol. 1997 May-Jun;10(3):136-45. Review.

PMID:
9238621
5.

[Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].

Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.

Nefrologia. 2002;22(5):463-9. Review. Spanish.

6.

Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.

Lim WH, Russ GR, Coates PT.

Nephrology (Carlton). 2006 Aug;11(4):355-66. Review.

PMID:
16889577
7.

Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.

Taylor AL, Marcus R, Bradley JA.

Crit Rev Oncol Hematol. 2005 Oct;56(1):155-67. Review.

PMID:
15979320
8.

Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.

Sivaraman P, Lye WC.

Biomed Pharmacother. 2001 Sep;55(7):366-8. Review.

PMID:
11669498
9.
10.

Posttransplant lymphoproliferative disorder.

Everly MJ, Bloom RD, Tsai DE, Trofe J.

Ann Pharmacother. 2007 Nov;41(11):1850-8. Epub 2007 Oct 16. Review. Erratum in: Ann Pharmacother. 2007 Dec;41(12):2074.

PMID:
17940127
11.

Post-transplant lymphoproliferative disorders.

Singavi AK, Harrington AM, Fenske TS.

Cancer Treat Res. 2015;165:305-27. doi: 10.1007/978-3-319-13150-4_13. Review.

PMID:
25655616
12.

Managing the challenge of PTLD in liver and bowel transplant recipients.

Lauro A, Arpinati M, Pinna AD.

Br J Haematol. 2015 Apr;169(2):157-72. doi: 10.1111/bjh.13213. Epub 2014 Nov 7. Review.

PMID:
25377273
14.

Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options.

Végso G, Hajdu M, Sebestyén A.

Pathol Oncol Res. 2011 Sep;17(3):443-54. doi: 10.1007/s12253-010-9329-8. Epub 2010 Dec 31. Review.

PMID:
21193979
15.
16.

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Jagadeesh D, Woda BA, Draper J, Evens AM.

Curr Treat Options Oncol. 2012 Mar;13(1):122-36. doi: 10.1007/s11864-011-0177-x. Review.

PMID:
22241590
17.

Malignancies after pediatric kidney transplantation: more than PTLD?

Mynarek M, Hussein K, Kreipe HH, Maecker-Kolhoff B.

Pediatr Nephrol. 2014 Sep;29(9):1517-28. doi: 10.1007/s00467-013-2622-5. Epub 2013 Sep 24. Review.

PMID:
24061645
18.

The post-transplant lymphoproliferative disorder-a literature review.

Shroff R, Rees L.

Pediatr Nephrol. 2004 Apr;19(4):369-77. Epub 2004 Feb 21. Review.

PMID:
14986084
19.

Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders.

Morscio J, Tousseyn T.

World J Transplant. 2016 Sep 24;6(3):505-16. doi: 10.5500/wjt.v6.i3.505. Review.

20.

Post-transplant lymphoproliferative disorders.

Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S.

Nat Rev Dis Primers. 2016 Jan 28;2:15088. doi: 10.1038/nrdp.2015.88. Review.

PMID:
27189056

Supplemental Content

Support Center